These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24522668)

  • 1. Gadolinium-containing endohedral fullerenes: structures and function as magnetic resonance imaging (MRI) agents.
    Ghiassi KB; Olmstead MM; Balch AL
    Dalton Trans; 2014 May; 43(20):7346-58. PubMed ID: 24522668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadofullerene MRI contrast agents.
    Bolskar RD
    Nanomedicine (Lond); 2008 Apr; 3(2):201-13. PubMed ID: 18373426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
    Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gd3N@C84(OH)x: a new egg-shaped metallofullerene magnetic resonance imaging contrast agent.
    Zhang J; Ye Y; Chen Y; Pregot C; Li T; Balasubramaniam S; Hobart DB; Zhang Y; Wi S; Davis RM; Madsen LA; Morris JR; LaConte SM; Yee GT; Dorn HC
    J Am Chem Soc; 2014 Feb; 136(6):2630-6. PubMed ID: 24432974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrochalarones: a novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast.
    MacFarland DK; Walker KL; Lenk RP; Wilson SR; Kumar K; Kepley CL; Garbow JR
    J Med Chem; 2008 Jul; 51(13):3681-3. PubMed ID: 18558670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain of a 500-fold sensitivity on an intravital MR contrast agent based on an endohedral gadolinium-cluster-fullerene-conjugate: a new chance in cancer diagnostics.
    Braun K; Dunsch L; Pipkorn R; Bock M; Baeuerle T; Yang S; Waldeck W; Wiessler M
    Int J Med Sci; 2010 May; 7(3):136-46. PubMed ID: 20567614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of fullerenes in nanomedicine: an update.
    Dellinger A; Zhou Z; Connor J; Madhankumar AB; Pamujula S; Sayes CM; Kepley CL
    Nanomedicine (Lond); 2013 Jul; 8(7):1191-208. PubMed ID: 23837857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents.
    Tóth E; Bolskar RD; Borel A; González G; Helm L; Merbach AE; Sitharaman B; Wilson LJ
    J Am Chem Soc; 2005 Jan; 127(2):799-805. PubMed ID: 15643906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging using gadolinium-based contrast agents.
    Mitsumori LM; Bhargava P; Essig M; Maki JH
    Top Magn Reson Imaging; 2014 Feb; 23(1):51-69. PubMed ID: 24477166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology and MRI contrast enhancement.
    Matson ML; Wilson LJ
    Future Med Chem; 2010 Mar; 2(3):491-502. PubMed ID: 21426177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of a family of gadolinium-containing endohedral fullerenes and the isolation and crystallographic characterization of one member as a metal-carbide encapsulated inside a large fullerene cage.
    Yang H; Lu C; Liu Z; Jin H; Che Y; Olmstead MM; Balch AL
    J Am Chem Soc; 2008 Dec; 130(51):17296-300. PubMed ID: 19053424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications.
    Helm L
    Future Med Chem; 2010 Mar; 2(3):385-96. PubMed ID: 21426173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High relaxivity trimetallic nitride (Gd3N) metallofullerene MRI contrast agents with optimized functionality.
    Zhang J; Fatouros PP; Shu C; Reid J; Owens LS; Cai T; Gibson HW; Long GL; Corwin FD; Chen ZJ; Dorn HC
    Bioconjug Chem; 2010 Apr; 21(4):610-5. PubMed ID: 20218678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics.
    Meng J; Wang DL; Wang PC; Jia L; Chen C; Liang XJ
    J Nanosci Nanotechnol; 2010 Dec; 10(12):8610-6. PubMed ID: 21121373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
    Caravan P
    Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregation studies of the water-soluble gadofullerene magnetic resonance imaging contrast agent: [Gd@C82O6(OH)16(NHCH2CH2COOH)8]x.
    Shu CY; Zhang EY; Xiang JF; Zhu CF; Wang CR; Pei XL; Han HB
    J Phys Chem B; 2006 Aug; 110(31):15597-601. PubMed ID: 16884284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallofullerenes: a new class of MRI agents and more?
    Fatouros PP; Shultz MD
    Nanomedicine (Lond); 2013 Nov; 8(11):1853-64. PubMed ID: 24156489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Interleukin-13 Amino-Coated Gadolinium Metallofullerene Nanoparticle for Targeted MRI Detection of Glioblastoma Tumor Cells.
    Li T; Murphy S; Kiselev B; Bakshi KS; Zhang J; Eltahir A; Zhang Y; Chen Y; Zhu J; Davis RM; Madsen LA; Morris JR; Karolyi DR; LaConte SM; Sheng Z; Dorn HC
    J Am Chem Soc; 2015 Jun; 137(24):7881-8. PubMed ID: 26022213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.